Photoacoustic (PA)
imaging has attracted much attention as a new
biomedical imaging modality due to its ultrasonic spatial resolution,
optical contrast resolution, and deeper imaging depth than other optical
imaging modalities. Exogenous PA contrast agents have been developed,
with high optical absorbance at a desired wavelength, to improve their
imaging sensitivity over background signal produced from endogenous
nontargeted absorbers. However, the current approaches to PA imaging
are based on a nonoptimal detection of PA signal, due to the fact
that the PA signal contains a broad range of frequency components,
whereas an ultrasound transducer is only capable of receiving signals
within a certain frequency range. As a result, much of the signal
generated by PA contrast agent is lost when received by an ultrasound
transducer. In this study, we propose a new concept for PA contrast
enhancement. This method uses chromophore-embedded microbubbles as
selective resonance frequency amplifiers; only the PA signal energy
within a desired spectral bandwidth can be selectively increased by
adjusting the microbubble size. Therefore, the efficiency of the signal
reception by an ultrasound transducer can be improved when the operating
frequency of the transducer is similar to the amplified spectral bandwidth,
thus allowing for more sensitive PA imaging. This new concept was
validated using a porphyrin-phospholipid microbubble (p-MB) in vitro
and in vivo experiments, which showed that the p-MBs increased the
PA signals up to 40.94 times, compared with the PA signals from the
freely dispersed porphyrin-embedded liposomes (i.e., porphysomes).